Methodological aspects and clinical value of chromogranin A assessment;Méthodologie et utilisation du dosage de la chromogranine A en biologie clinique

Medecine/Sciences

Volumn 17, Issue 4, 2001, Pages 438-447

  Baudin, E ^a   Degorce, F ^a  

^a CIS Bio International   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; MONOCLONAL ANTIBODY;

DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; METHODOLOGY; NEUROENDOCRINE TUMOR; PLASMA; PROGNOSIS; REVIEW;

EID: 0035063662     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1943     Document Type: Review

References (45)

1. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma
2. Synaptophysin and chromogranins/secretogranins - Widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis?
3. Les tumeurs neuroendocrines gastro-entéropancréatiques
4. Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla
5. Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma
6. Specific endocrine tissue marker defined by a monoclonal antibody
7. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody
8. Distinct patterns of chromogranin A-related species can be demonstrated in endocrine cells
9. Characterisation of circulating chromogranin A in human cancer patients
10. Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues
11. Intracellular and extracellular processing of chromogranin-A-determination of cleavage sites
12. Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: Correspondence in patients with neuroendocrine neoplasia
13. Rapid radioimmunoassay of circulating chromogranin A: In vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure
14. Immunoluminometric assay of chromogranin A in serum with commercially available reagents
15. Enzyme linked immunosorbent assay for chromogranin A
16. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours
17. Simple enzyme immunoassay for the measurement of immunoreactive chromogranin A in human plasma, urine and saliva
18. A new human chromogranin A (CGA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain
19. Recombinant human chromogranin A: Expression, purification and characterization of the N-terminal derived peptides
20. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours
21. Secretion of chromogranin A by peptide-producing endocrine neoplasms
22. Chromogranin A storage and secretion: Sensitivity and specificity for the diagnosis of phaeochromocytoma
23. Chromogranin A as tumor marker in medullary thyroid carcinoma
24. Chromogranin A in children with neuroblastoma
25. Plasma levels of chromogranin A are directly proportional to tumour burden in neuroblastoma
26. Elevated serum chromogranin A concentrations in small-cell lung cercinoma
27. Chromogranin A, a significant prognostic factor in small cell lung cancer
28. Chromogranin A as a serum marker for neuroendocrine tumors: Comparison with neuron-specific enolase and correlation with immunohistochemical findings
29. Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuron-specific enolase and the α-subunit of glycoprotein hormones
30. Source of plasma chromogranin A, elevation in gastrinoma patients
31. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas
32. Sensitivity and specificity of new ELISA method for determination of chromogranin A in the diagnosis of phaeochromocytoma and neuroblastoma
33. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma
34. Plasma chromogranin A in phaeochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones
35. Chromogranin A and the α-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma
36. A comparison between the diagnostic value of gonadotropins, α-subunit, and chromogranin A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, α-subunit-secreting, ans gonadotroph pituitary adenomas
37. Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center
38. Chromogranins-new sensitive markers for neuro-endocrine tumours
39. Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer
40. Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors
41. Levels and molecular properties of secretoneurin-immunoreactivity in the serum and urine of control and neuroendocrine tumor patients
42. Chromogranin A and pancreastatin-like immmunoreactivity in serum of gastrinoma patients
43. Chromogranin A measurement in neuroendocrine tumors
44. Suppression of chromogranin A release from neuroendocrine sources in man: Pharmacological studies
45. Chromogranin A, neuron-specific enolase and synaptopysin as neuroendocrine cell markers in the diagnosis of tumours of the gastro-entero-pancreatic system